Portfolio company
Cytonus Therapeutics
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This biotechnology company develops engineered cell-based delivery platforms to transport therapeutic payloads for treating cancers, inflammatory diseases, and cognitive disorders.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
EdiTy Therapeutics
This company develops immune cell delivery platforms to transport therapeutic proteins into diseased cells for patients with cancer and genetic disorders.
Cellergy Therapeutics
This biotechnology company develops purified mitochondrial transplantation therapies to treat patients with neurodegenerative diseases, muscle degeneration and age-related conditions.
CARGO Therapeutics
This biotechnology company develops engineered cell therapies to treat cancer patients with relapsed or resistant lymphoma.
Century Therapeutics
This biotechnology company develops induced pluripotent stem cell-derived therapies to treat patients with cancer and autoimmune diseases.
Transforming cells into cures
This company develops a cellular engineering platform to design and optimize cell therapies for biopharmaceutical developers and research institutions.
PNAS Therapeutics
This company develops a one-step drug delivery platform to create regenerative therapies and enhanced pharmaceutical formulations for biotechnology and healthcare partners.
Chameleon Biosciences
This company develops immune-evading gene therapy delivery platforms for pharmaceutical firms and patients with genetic disorders.
Aera Therapeutics
This biotechnology company develops delivery platforms for genetic medicines to treat various diseases for biopharmaceutical partners and patients.
